Back to UBS Group AG UBS Group AG

ABCLABCL
23 quarters

Position history for UBS Group AGUBS Group AG's holdings in ABCELLERA BIOLOGICS INC

UBS Group AG holds 1.9M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $14.7M as of 2026-Q2. The position was decreased (-55.6% shares). ABCL represents 0.0% of UBS Group AG's portfolio.

Current Value

$14.7M

Current Shares

1.9M

Total Value Change

+$14.7M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.9M
-55.6%
$14.7M0.0%$7.85
0
2026-Q1
Increased
4.2M
+117.0%
$14.7M0.0%$3.71
45
2025-Q4
Decreased
1.9M
-22.1%
$6.6M0.0%$3.45
0
2025-Q3
Decreased
2.5M
-27.8%
$12.5M0.0%$4.87
0
2025-Q2
Decreased
3.4M
-32.2%
$11.8M0.0%$3.61
0
2025-Q1
Increased
5.1M
+157.3%
$11.3M0.0%$2.31
45
2024-Q4
Increased
2M
+8984.1%
$5.8M0.0%$2.82
44
2024-Q3
Decreased
21,745
-77.1%
$56,5370.0%$2.61
0
2024-Q2
Decreased
94,991
-6.8%
$281,1740.0%$2.96
0
2024-Q1
Increased
101,975
+3979.0%
$461,9470.0%$4.53
39
2023-Q4
New
2,500
-
$14,2750.0%$5.71
27
2023-Q3
Exited
0
-100.0%
$00.0%$4.60
0
2023-Q2
Decreased
13,366
-80.0%
$86,3440.0%$6.58
0
2023-Q1
Increased
66,898
+51.2%
$504,4110.0%$7.42
34
2022-Q4
Decreased
44,246
-53.4%
$448,2120.0%$10.13
0
2022-Q3
Increased
94,838
+129.3%
$938,0000.0%$9.85
40
2022-Q2
Decreased
41,355
-33.8%
$440,0000.0%$10.11
0
2022-Q1
Decreased
62,425
-21.2%
$609,0000.0%$9.75
0
2021-Q4
Increased
79,191
+24.9%
$1.1M0.0%$14.34
31
2021-Q3
Increased
63,407
+54.6%
$1.3M0.0%$19.45
36
2021-Q2
Increased
41,018
+1236.5%
$902,0000.0%$21.28
40
2021-Q1
Increased
3,069
+383x
$104,0000.0%$26.68
24
2020-Q4
New
8
-
$00.0%$41.10
17

Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used